ASX - Delayed Quote AUD

Imagion Biosystems Limited (IBX.AX)

0.0740 0.0000 (0.00%)
As of March 28 at 3:50 PM GMT+11. Market Open.
Advanced Chart
Loading Chart for IBX.AX
DELL
  • Previous Close 0.0740
  • Open 0.0810
  • Bid 0.0730 x 33516900
  • Ask 0.0820 x 74428200
  • Day's Range 0.0740 - 0.0810
  • 52 Week Range 0.0730 - 1.4400
  • Volume 13,188
  • Avg. Volume 68,292
  • Market Cap (intraday) 2.416M
  • Beta (5Y Monthly) 1.89
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4300
  • Earnings Date Feb 29, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Imagion Biosystems Limited provides medical imaging technologies using magnetic resonance. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the MagSense nanoparticles for enhancing brain tumor imaging and diagnosis. The company was incorporated in 2016 and is based in San Diego, California.

imagionbiosystems.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Diagnostics & Research

Industry

More about Imagion Biosystems Limited

Recent News: IBX.AX

View More
View More

Performance Overview: IBX.AX

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IBX.AX
79.15%
S&P/ASX 200 [XJO]
0.03%

1-Year Return

IBX.AX
88.06%
S&P/ASX 200 [XJO]
3.72%

3-Year Return

IBX.AX
98.72%
S&P/ASX 200 [XJO]
7.70%

5-Year Return

IBX.AX
92.99%
S&P/ASX 200 [XJO]
18.83%

Compare To: IBX.AX

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

IBX.AX
Imagion Biosystems Limited
0.0740
0.00%
Mkt Cap AUD 2.416M
Industry Diagnostics & Research
GTG.AX
Genetic Technologies Limited
0.1250
+8.70%
Mkt Cap AUD 16.527M
Industry Diagnostics & Research

Statistics: IBX.AX

View More

Valuation Measures

Annual
As of 4/26/2024

  • Market Cap

    2.42M

  • Enterprise Value

    9.33M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.37

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    5.67

  • Enterprise Value/EBITDA

    -0.81

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -252.26%

  • Return on Assets (ttm)

    -99.05%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    5.18M

  • Net Income Avi to Common (ttm)

    -13.07M

  • Diluted EPS (ttm)

    -0.4300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    227.08k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -4.38M

View More

Company Insights: IBX.AX

People Also Watch

ADN.AX Andromeda Metals Limited
0.0170
-10.53%
 
VML.AX Vital Metals Limited
0.0050
0.00%
 
AR9.AX archTIS Limited
0.0900
+1.12%
 
MGT.AX Magnetite Mines Limited
0.2750
+3.77%
 
RHY.AX Rhythm Biosciences Limited
0.0840
0.00%
 
NVA.AX Nova Minerals Limited
0.2900
-1.69%
 
OAR.AX OAR Resources Limited
0.0010
-50.00%
 
FFG.AX Fatfish Group Limited
0.0170
-10.53%
 
IMU.AX Imugene Limited
0.0780
-6.02%
 
LRS.AX Latin Resources Limited
0.2150
+7.50%
 
ICI.AX iCandy Interactive Limited
0.0220
0.00%
 
PAB.AX Patrys Limited
0.0090
0.00%
 
SOR.AX Strategic Elements Ltd
0.0620
-3.13%
 
DXB.AX Dimerix Limited
0.3150
-5.97%
 
WBT.AX Weebit Nano Limited
2.9600
-0.67%
 
ADO.AX AnteoTech Limited
0.0220
-4.35%